NCT02188186View on ClinicalTrials.gov

Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2018

Study Completion Date

September 30, 2018

Conditions
Type 2 Diabetes
Interventions
DRUG

Initial triple combination

Initial triple combination arm

DRUG

Conventional treatment

Conventioanl treament with dose escalation

Trial Locations (1)

463-707

Seoul National University Bundang Hospital, Seongnam-si

All Listed Sponsors
lead

Seoul National University Bundang Hospital

OTHER

NCT02188186 - Therapeutic Efficacy of Triple Combination in Drug-naïve Korean Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter